Navigation Links
Neuralstem Updates ALS Clinical Trial Progress
Date:2/10/2011

euralstem's spinal cord stem cells in the treatment of ALS, the first FDA-approved ALS stem cell trial, has been underway since January, 2010. The trial plans to enroll up to 18 ALS patients, who will be examined at regular intervals post-surgery.

All of the first six patients treated in the trial were non-ambulatory. Of these, the first three received five injections each, unilaterally, in the lumbar region of the spinal cord. The next three patients received ten injections each, bilaterally in the lumbar region. All remaining trial patients are ambulatory, and therefore represent earlier stages of disease progression. Of the ambulatory group, the first three patients received five injections each, unilaterally, in the lumbar region. The next three, which have just been approved, will receive ten injections each, bilaterally, in the lumbar region. After the required FDA approval, the final six patients in the trial will receive injections in the cervical region.  

While the trial is evaluating only the safety of the cells and procedure, it includes exploratory endpoints including  attenuation of motor function loss, maintenance of respiratory capacity, and stabilization of patients along the ALS functional rating scale.

The Emory ALS Center has posted the relevant trial information for patients on its website at http://www.neurology.emory.edu/ALS/Stem%20Cell.html.  

About Neuralstem

Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem is in a FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's disease, which has been rewarded Orphan Drug Status
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
2. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
3. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
4. Neuralstems ALS Trial on Clinical Hold
5. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
6. Neuralstem Announces Issuance of Core Technology Patent in Europe
7. K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™
8. ISTA Pharmaceuticals Achieves 2010 Revenue and Earnings Guidance; Provides 2011 Financial Guidance and Updates Key Plans
9. Vista Partners Updates Coverage on Pro-Pharmaceuticals, Inc.; Maintains Target Price of $2.10
10. Access Pharmaceuticals Updates MuGard Website With First Patient Testimonial Video
11. Intercell AG Announces Q3 2010 Results and Updates on R&D Progress and Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015   The New York Times ... internationally acclaimed plastic surgeon, Dr. Rod Rohrich . ... is proven to reduce fat deposits under the chin. ... The active ingredient in Kybella, deoxycholic acid, dissolves ... the ability to reshape this area without surgery. "So ...
(Date:5/4/2015)... , May 4, 2015 Former NASA ... News online last week where he discussed Theradome™, the ... be FDA-cleared. The FOX segment shows firsthand how, via ... affordable hair loss solution that will not require surgery ... the mitochondria at the base of the hair follicle, ...
(Date:5/4/2015)... Conn. , May 4, 2015 /PRNewswire/ ... market private equity firm, announced today that ... portfolio company, BioPharm Communications. BioPharm specializes in the ... programs for the pharmaceutical and biotechnology industries. ... repaid to its shareholders half of their ...
Breaking Medicine Technology:Dr. Rod Rohrich Provides Medical Expertise on Kybella 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 3FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2
... , ST. LOUIS , ... today announced that it will broadcast its fourth quarter earnings results ... Thursday, February 4, 2010 at 11:00 a.m. Central Time ... through InterCall at http://tinyurl.com/yi4q09 .  Access to the live audio ...
... , RICHMOND, Calif. , Jan. 27 ... the company will release its fourth quarter and full year 2009 financial ... The press release will be followed by a conference call at ... telephone and webcast. During the conference call, the company will review the ...
Cached Medicine Technology:Young Innovations, Inc. Provides 4th Quarter Conference Call Details 2Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast 2
(Date:5/4/2015)... The American Telemedicine Association (ATA) today released an update ... in coverage and reimbursement, and physician practice standards and ... Reports last September, many state regulating bodies responded by ... delivery in their state,” said Jonathan Linkous, CEO of ... nation, ATA reevaluated the indicators for each state and ...
(Date:5/4/2015)... 2015 METTLER TOLEDO has announced ... Data Integrity in a GXP Regulated Laboratory ", ... This webinar will be presented on May 27, ... integrity is a critical component of pharmaceutical product ... However, in recent years an increasing number of ...
(Date:5/4/2015)... Washington, DC (PRWEB) May 04, 2015 ... of Kit Check as a finalist for the EY ... Washington Region. The awards program recognizes entrepreneurs who ... innovation, financial performance and personal commitment to their businesses ... finalist by a panel of independent judges. Award ...
(Date:5/4/2015)... Ticket Down is a reputable source for authentic ... in Columbia, South Carolina. Fans of Paul McCartney have ... tour which originally kicked off in 2013. The most visited ... the legendary performer recently announced that he would be adding ... June 21st, in Charlottesville, VA at John Paul Jones Arena ...
(Date:5/4/2015)... San Diego, CA (PRWEB) May 04, 2015 ... hosted a ribbon cutting ceremony at their brand new, ... of this year. The new building will not only ... patient population, but will also offer community and educational ... , The new facility is located next door to ...
Breaking Medicine News(10 mins):Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:EY announces Kit Check CEO and Co-founder Kevin MacDonald as an EY Entrepreneur Of The Year® 2015 Award finalist in the Greater Washington Region 2Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3
... Oct. 28 A few spaces remain for the ... Symposium on Nov. 4-5, 2009. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ... writers and journalists and will focus on how FDA ... , This year,s symposium will feature an address by ...
... 28 If we get a boo-boo, we might know to ... kiss it and make it all better. But, what if ... us who aren,t prepared for dental emergencies can quickly get back ... Company at: , http://inr.mediaseed.tv/oneClip_C/?feed=Ss8P5Rb1iQulYDAELUR0M_kpwKp_6YSM , Medialink ...
... Oct. 28 Collagen Matrix, Inc., the leader in ... Shu-Tung Li, the Company,s Founder, President, and Chief Executive ... Executive of the Year category of the 2009 New ... Politziner and Mattia, Certified Public Accountants and Consultants. ...
... Inc . (Pink Sheets: JEDM) ( www.jedimindinc.com ) ... excellent cash position to expand both the gaming and medical divisions ... in excess of $500,000 of working capital which is being used ... computer hardware and software applications to the latest standards. , ...
... Research Foundation (LRF) is pleased to announce that David ... Thomas Kipps, MD, PhD, Moores Cancer Center, University of ... round of funding under the Foundation,s Chronic Lymphocytic Leukemia ... Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) are ...
... and mental health in study , WEDNESDAY, Oct. 28 ... the emotional and mental well-being of breast cancer patients, ... 130 patients at Saint Joseph Hospital in Chicago, aged ... meditation group or to a usual care control group. ...
Cached Medicine News:Health News:Shu-Tung Li, Founder and CEO of Collagen Matrix, Inc. Honored as 2009 New Jersey Executive of the Year Finalist and Company Named One of Fifty Fastest Growing Companies 2Health News:Jedi Mind, Inc. in Excellent Financial Shape to Expand Business 2Health News:Lymphoma Research Foundation announces recipients of CLL/SLL Research Initiative grants 2Health News:Meditation May Reduce Stress in Breast Cancer Patients 2
... an integral part of the enzymatic cascade ... as well as the degradation of Bradykinin. ... is primarily located in endothelial cells. ACE ... for sarcoidosis and myocardial infarction but is ...
... and quantitative evaluation of pancreatic b-cell function is ... post-diagnostic study of the natural history of diabetes ... as a guide to the correct choice of ... to assess b-cell function because of the ...
... hormone responsible for the control of glucose metabolism. ... the islets of Langerhans as the precursor, proinsulin, ... Both are secreted in equimolar amounts into ... is comprised of two polypeptide chains, the A-chain ...
... quantitative evaluation of pancreatic -cell function is not ... study of the natural history of diabetes mellitus, ... a guide to the correct choice of treatment. ... -cell function because of the large and variable ...
Medicine Products: